Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate a novel vancomycin intraosseous administration protocol vs a standard IV vancomycin administration protocol for primary total hip arthroplasty patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Methodist Hospital Research Institute
NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more
NCT07406893 · Joint Arthroplasty, Shoulder, and more
NCT06889701 · Periprosthetic Joint Infection (PJI)
NCT06426836 · Pharmacokinetics, Amoxicillin-clavulanate, and more
NCT02456974 · Pharmacokinetics, Amoxicillin-clavulanate, and more
Houston Methodist Hospital
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions